Fig. 1From: Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysisFlow diagram of the study. aConcomitant malignancies other than gastric cancer (n=6), metastatic carcinoma not confined to gastric origin (n = 3), and esophageal carcinoma with gastric invasion (n = 2). GC, gastric cancer; GEJC, gastroesophageal junction cancer; NCKUH, National Cheng Kung University Hospital; CCRT, concurrent chemoradiotherapy; LN, lymph node; PPS, propensity scoreBack to article page